Publications by authors named "H Dolo"
Understanding the barriers and facilitators related to never treatment during mass drug administration among mobile and migrant populations in Mali: a qualitative exploratory study.
BMJ Glob Health
October 2024
Article Synopsis
- A study examines why high-mobility individuals in Mali have never received preventive chemotherapy during mass drug administration (MDA) for neglected tropical diseases, highlighting the need for high treatment coverage to eliminate these illnesses as public health issues.
- Researchers conducted qualitative interviews and focus groups with displaced persons, nomads, and economic migrants to gather insights on their experiences and challenges related to MDA.
- Key reasons for not receiving treatment included geographic mobility, lack of awareness, negative rumors, fear of side effects, and logistical challenges, leading to recommendations for community involvement and flexible intervention strategies to improve access.
Introduction: Neurological disorders (ND) have a high incidence in sub-Saharan Africa (SSA). In this region, systemic challenges of conventional medicine (CM) and cultural beliefs have contributed to a large utilization of traditional medicine (TM). Yet, data on TM and those who use it in the treatment of ND in SSA are scarce.
View Article and Find Full Text PDFBackground: The sero-epidemiological characteristics of SARS-CoV-2 infections in Mali are not yet well understood. This study assessed SARS-CoV-2 antibody seroprevalence and factors associated with antibody responses in the general population of Bamako, the capital city and epicenter of COVID-19, to assess the magnitude of the pandemic and contribute to control strategy improvements in Mali.
Methods: A cross-sectional survey was conducted in September 2022 to collect sociodemographic information, clinical characteristics, comorbid factors, and blood samples.
Article Synopsis
- - Lymphedema (LE), a serious condition resulting from lymphatic filariasis, is primarily treated through limb hygiene and local care, with a study exploring doxycycline's potential benefits.
- - A multicenter trial in Mali tested doxycycline (200 mg/day) against a placebo for 6 weeks in patients with LE stages 1-3, measuring the disease's progression over 24 months.
- - Results showed no significant difference in LE progression between the doxycycline and placebo groups, but both experienced reduced acute adenolymphangitis attacks; doxycycline was well tolerated but not more effective than hygiene alone.
Background: Our recent studies have shown headache disorders to be very common in the central and western sub-Saharan countries of Benin and Cameroon. Here we report headache in nearby Mali, a strife-torn country that differs topographically, culturally, politically and economically. The purposes were to estimate headache-attributed burden and need for headache care.
View Article and Find Full Text PDF